Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pacira BioSciences (Nasdaq: PCRX) granted inducement equity awards on May 4, 2026 to ten new employees under its Amended and Restated 2014 Inducement Plan as permitted by Nasdaq Listing Rule 5635(c)(4).

Rhea-AI Summary

Pacira BioSciences (Nasdaq: PCRX) granted inducement equity awards on May 4, 2026 to ten new employees under its Amended and Restated 2014 Inducement Plan as permitted by Nasdaq Listing Rule 5635(c)(4).

The Committee approved options for an aggregate of 36,800 shares and restricted stock units for 27,700 shares. Options carry a 10-year term, four-year vesting; RSUs vest annually over four years beginning May 4, 2027, and awards use a $24.69 exercise price for options.

Argus May 8 session

-2.07% close to close Open Argus

Details

News Market Reaction – PCRX

On May 8, the day this news came out, PCRX closed 2.07% below the previous close.

Data tracked by StockTitan Argus for the May 8 session.

Market Context

This announcement details routine inducement equity awards to new hires, including options on 36,800...

Analysis

This announcement details routine inducement equity awards to new hires, including options on 36,800 shares and 27,700 RSUs at an exercise price of $24.69, vesting over four years. Such grants align with Nasdaq Listing Rule 5635(c)(4) and support talent recruitment. In context, PCRX was trading near its 200-day moving average and below its 52‑week high, with recent news-flow dominated by earnings, proxy materials, and clinical data. Investors may monitor how ongoing governance, compensation, and clinical milestones evolve from here.

Key Figures

New employees: 10 employees Stock options granted: 36,800 shares RSUs granted: 27,700 shares +5 more

New employees

10 employees

Recipients of inducement equity awards under 2014 Inducement Plan

Stock options granted

36,800 shares

Aggregate options to three employees as inducement awards

RSUs granted

27,700 shares

Aggregate restricted stock units to ten employees

Option term

10 years

Contractual life of inducement stock options

Vesting period

4 years

Option vesting schedule with 25% after year one then quarterly

Option exercise price

$24.69 per share

Closing price on Nasdaq Global Select Market on grant date May 4, 2026

Initial vesting

25 percent

Options vest 25% on first anniversary of employment start date

Subsequent vesting period

36 months

Remaining option vesting in equal quarterly installments

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Stockholder letter

   24h Move

   -4.4%

   Mailing of letter to stockholders ahead of upcoming annual meeting.

2. Apr 30

   Earnings results

   24h Move

   -4.1%

   Q1 2026 revenue growth, non-opioid portfolio update, and reiterated guidance.

3. Apr 28

   Proxy materials

   24h Move

   -1.1%

   Definitive proxy filing and shareholder letter highlighting strategy and milestones.

4. Apr 27

   Clinical real-world data

   24h Move

   +4.2%

   Real-world EXPAREL data showing reduced opioid use and medical costs.

5. Apr 16

   Earnings date notice

   24h Move

   +1.8%

   Announcement of date and time for Q1 2026 earnings release and call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq listing rule 5635(c)(4), stock options, restricted stock units

3 terms

nasdaq listing rule 5635(c)(4) regulatory

"In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved..."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

stock options financial

"Three employees received stock options to purchase an aggregate of 36,800 shares..."

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

restricted stock units financial

"ten employees received restricted stock units for an aggregate of 27,700 shares..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on May 4, 2026 to ten new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.

Three employees received stock options to purchase an aggregate of 36,800 shares of Pacira common stock and ten employees received restricted stock units for an aggregate of 27,700 shares of Pacira common stock. The stock options have a 10-year term and a four-year vesting schedule with 25 percent of the underlying shares vesting on the first anniversary of the recipient’s first day of employment and in successive equal quarterly installments over the 36 months thereafter. The stock options have an exercise price of $24.69 per share, the closing trading price of Pacira common stock on the Nasdaq Global Select Market on the date of grant. Each restricted stock unit represents the contingent right to receive one share of Pacira common stock and the restricted stock unit awards vest annually in four equal installments beginning on May 4, 2027.

Vesting of the equity awards is subject to the employee’s continued employment with Pacira. Each equity award is also subject to the terms and conditions of an award agreement.

About Pacira

Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL^® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA^® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera_®º, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing a pipeline of clinical-stage assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy, is in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit www.pacira.com.

Investor Contact:
Susan Mesco, (973) 451-4030
susan.mesco@pacira.com

Media Contact:
Sara Marino, (973) 370-5430
sara.marino@pacira.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Pacira (PCRX) grant on May 4, 2026?

Pacira granted stock options totaling 36,800 shares and restricted stock units totaling 27,700 shares. According to the company, the awards were issued as inducements to ten new employees and approved under Nasdaq Listing Rule 5635(c)(4).

What are the key terms of the Pacira (PCRX) stock options granted May 4, 2026?

The options have a 10-year term and a four-year vesting schedule with 25% vesting after one year. According to the company, the exercise price was $24.69, the closing price on the grant date.

When do the restricted stock units granted by Pacira (PCRX) begin vesting?

The restricted stock units vest annually in four equal installments beginning on May 4, 2027. According to the company, each RSU represents the contingent right to receive one share and vesting requires continued employment.

Why did Pacira (PCRX) issue these inducement awards under Nasdaq Rule 5635(c)(4)?

The awards were approved as material inducements to new employees and authorized by the People & Compensation Committee without stockholder approval. According to the company, the grants comply with Nasdaq Listing Rule 5635(c)(4).